Amedeo Smart

Free Medical Literature Service



Breast Cancer

  Free Subscription

Articles published in
Mod Pathol
    August 2017
  1. BARTELS S, Christgen M, Luft A, Persing S, et al
    Estrogen receptor (ESR1) mutation in bone metastases from breast cancer.
    Mod Pathol. 2017 Aug 11. doi: 10.1038/modpathol.2017.
    >> Share

    July 2017
  2. AGUILAR-MAHECHA A, Lafleur J, Pelmus M, Seguin C, et al
    The identification of challenges in tissue collection for biomarker studies: the Q-CROC-03 neoadjuvant breast cancer translational trial experience.
    Mod Pathol. 2017 Jul 28. doi: 10.1038/modpathol.2017.
    >> Share

    June 2017
  3. BUISSERET L, Desmedt C, Garaud S, Fornili M, et al
    Reliability of tumor-infiltrating lymphocyte and tertiary lymphoid structure assessment in human breast cancer.
    Mod Pathol. 2017 Jun 16. doi: 10.1038/modpathol.2017.
    >> Share

    March 2017
  4. PANG JB, Savas P, Fellowes AP, Mir Arnau G, et al
    Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer.
    Mod Pathol. 2017 Mar 24. doi: 10.1038/modpathol.2017.
    >> Share

    January 2017
  5. YOUSEF EM, Furrer D, Laperriere DL, Tahir MR, et al
    MCM2: An alternative to Ki-67 for measuring breast cancer cell proliferation.
    Mod Pathol. 2017 Jan 13. doi: 10.1038/modpathol.2016.
    >> Share

  6. VIEIRA AF, Dionisio MR, Gomes M, Cameselle-Teijeiro JF, et al
    P-cadherin: a useful biomarker for axillary-based breast cancer decisions in the clinical practice.
    Mod Pathol. 2017 Jan 13. doi: 10.1038/modpathol.2016.
    >> Share

  7. DOEBAR SC, Slaets L, Cardoso F, Giordano SH, et al
    Male breast cancer precursor lesions: analysis of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program.
    Mod Pathol. 2017 Jan 13. doi: 10.1038/modpathol.2016.
    >> Share

    October 2016
  8. RUSCHOFF J, Lebeau A, Kreipe H, Sinn P, et al
    Assessing HER2 testing quality in breast cancer: variables that influence HER2 positivity rate from a large, multicenter, observational study in Germany.
    Mod Pathol. 2016 Oct 21. doi: 10.1038/modpathol.2016.
    >> Share

  9. BALLARD M, Jalikis F, Krings G, Schmidt RA, et al
    'Non-classical' HER2 FISH results in breast cancer: a multi-institutional study.
    Mod Pathol. 2016 Oct 14. doi: 10.1038/modpathol.2016.
    >> Share

    August 2016
  10. SCHRIJVER WA, van der Groep P, Hoefnagel LD, Ter Hoeve ND, et al
    Influence of decalcification procedures on immunohistochemistry and molecular pathology in breast cancer.
    Mod Pathol. 2016 Aug 26. doi: 10.1038/modpathol.2016.
    >> Share

  11. KORNAGA EN, Klimowicz AC, Guggisberg N, Ogilvie T, et al
    Evaluation of three commercial progesterone receptor assays in a single tamoxifen-treated breast cancer cohort.
    Mod Pathol. 2016 Aug 26. doi: 10.1038/modpathol.2016.
    >> Share

  12. FUSCO N, Geyer FC, De Filippo MR, Martelotto LG, et al
    Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancer.
    Mod Pathol. 2016 Aug 5. doi: 10.1038/modpathol.2016.
    >> Share

    July 2016
  13. DENKERT C, Wienert S, Poterie A, Loibl S, et al
    Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group.
    Mod Pathol. 2016 Jul 1. doi: 10.1038/modpathol.2016.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016